How does IMPROvED work?
The goal of IMPROvED is to develop two prototype screening tests for pre-eclampsia.
We measure metabolomic and proteomic biomarkers, which we have identified as predictors of disease, and compare these measurements with clinical data from mothers. The result will be a simple algorithm which will determine risk status.
On the basis of our work to date, the two blood tests we have created have the potential to predict pre-eclampsia risk with an unprecedented accuracy.
IMPROvED is supported by a pool of talent which includes 4 small enterprises and 8 academic institutions.